Why the primary cancer record decides the review
A brain metastasis is not a standalone diagnosis. It is a secondary deposit whose behaviour, likely treatment options and expected response depend heavily on where the cancer started, how it was originally confirmed and what treatment has already been given. That is why a review in China cannot begin with the brain images alone. The primary cancer record is the context that makes the brain findings interpretable.
In practice, this means the first question is not 'which hospital in China treats brain metastases?' but 'what exactly is the primary cancer, how was it confirmed, and what has already been done?' A file that contains only a recent brain MRI and a short summary leaves the receiving clinician unable to judge whether the intracranial disease is newly diagnosed, progressing after prior treatment, or stable. Each of those situations leads to a different discussion.
The primary cancer record also determines whether the case is even suitable for an overseas review. If the original pathology is unclear, if the primary site was never definitively established, or if the systemic treatment history is missing, the clinician may need to ask for clarification before offering any opinion. That is not a delay tactic; it is a limit of what can be assessed from an incomplete file.
The records that actually matter for a brain metastases enquiry
A generic checklist of 'all medical records' is not useful here. The relevant documents fall into four groups, and each answers a different question.
First, the primary cancer diagnosis. This includes the original pathology report, the date and method of diagnosis, the primary site, and any staging information. If the primary cancer was confirmed at another hospital, the original report is more useful than a later summary that repeats it.
Second, the brain-directed history. This covers any prior brain imaging, any previous brain surgery, whole-brain radiotherapy, stereotactic radiosurgery or other local treatment, and the dates and outcomes of those interventions. The receiving team needs to know whether the current brain findings are new or represent change after earlier treatment.
Third, the systemic treatment history. This includes chemotherapy, targeted therapy, immunotherapy, endocrine therapy or other systemic agents, with dates, agents and the reason each was stopped or changed. A list of drug names without dates or response is much less useful than a short chronological summary.
Fourth, the current question. The patient or family should state plainly what they want reviewed: a second opinion on the brain findings, an assessment of whether further local treatment is possible, a review of systemic options, or a broader care plan. The same records support different reviews depending on the question asked.
Local brain treatment and systemic care are separate histories
A frequent gap in an overseas enquiry is the mixing of local brain treatment with systemic cancer treatment. They are related but distinct. Local treatment addresses the brain lesions themselves, for example surgery or radiotherapy directed at intracranial disease. Systemic treatment addresses the cancer throughout the body, including the brain, through medicines that circulate.
The distinction matters because the two histories answer different questions. The local history tells the receiving clinician what has already been done to the brain and whether further local treatment is technically or clinically reasonable. The systemic history tells them what the cancer has already been exposed to and what options may remain.
When these are combined into a single paragraph such as 'treated with radiotherapy and chemotherapy in 2023', the reviewer loses the sequence, the intent and the outcome. A short table or dated list separating local brain treatment from systemic treatment is far more useful than a narrative summary.
Radiotherapy, for example, uses radiation to treat cancer, and the technique and schedule depend on the individual treatment plan. That is why the record should state what was actually delivered and when, rather than simply naming the modality.
What the receiving clinician still has to confirm
Even a well-organised file does not answer every question. Several points remain for the treating clinician to confirm directly, and the patient should expect those questions rather than treat them as obstacles.
Whether the original pathology is adequate for the current question. Sometimes the original biopsy is sufficient; sometimes the clinician will want to review the slides or consider further testing. That is a clinical judgement, not an administrative step.
Whether the brain imaging is recent enough and of suitable quality for the specific decision. Imaging performed at different centres with different protocols may not be directly comparable, and the clinician may ask for the original images rather than the reports alone.
Whether the prior local brain treatment has left any residual options. This depends on the type, dose and timing of prior treatment, which is why the record should include the actual treatment details rather than a summary.
Whether the patient is well enough to travel and to undergo any proposed assessment. That is a clinical decision for the treating team, not something that can be assumed from a records review.
How to prepare the file without over-collecting
The goal is a focused file, not a complete archive. Over-collecting creates noise and makes it harder for the reviewer to find the relevant history. A short, well-ordered set of documents is more useful than hundreds of pages of unrelated records.
Start with a one-page summary written by the patient or family. It should state the primary cancer diagnosis and date, the brain metastasis diagnosis and date, the local brain treatments with dates, the systemic treatments with dates, and the specific question being asked. This summary is not a substitute for the original reports, but it guides the reviewer.
Then attach the key original documents: the primary pathology report, the most recent brain imaging report and, where available, the images themselves, the most recent systemic treatment summary, and any prior brain treatment records. If a document is missing, note that clearly rather than leaving the reviewer to discover the gap.
Finally, keep the file in a consistent order and label each section. A reviewer who can find the primary pathology in seconds will spend more time on the actual clinical question.
- One-page summary with dates and the specific question.
- Original primary cancer pathology report.
- Most recent brain imaging report and images if available.
- Chronological local brain treatment history.
- Chronological systemic treatment history.
- A clear note of any missing documents.
What to ask before sending records to China
Before sending anything, it is worth asking the receiving service a few practical questions. These are not clinical questions, but they determine whether the review can proceed usefully.
Ask what format the records should be in, whether translated summaries are needed, and whether the original imaging is required or whether reports are sufficient for an initial review. Ask who will actually review the file and what the output will be: a written opinion, a discussion, or a recommendation for further assessment in China.
Ask what the review does not cover. A records-based opinion cannot confirm hospital acceptance, cannot establish eligibility for a specific treatment, and cannot replace an in-person assessment. Understanding those limits before sending records prevents disappointment later.
For a brain metastases case specifically, ask whether the reviewer needs the primary cancer pathology and the full brain treatment history, or whether a focused summary is enough for the first step. The answer will shape how much work the family needs to do before any clinical opinion is possible.
ChinaSpecialistCare can help organise a records-based review for a brain metastases case, including matching the enquiry to a relevant specialty and clarifying what the receiving team needs. The hospital and its clinicians decide suitability and any treatment plan.
A practical next step is to prepare the one-page summary described above and use the free initial enquiry to ask what the receiving team needs for this specific case. An initial enquiry does not require buying a proxy consultation, and no clinical decision should be delayed while an overseas review is arranged.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.